266 related articles for article (PubMed ID: 14634090)
1. MHC class II-peptide complexes in dendritic cell lipid microdomains initiate the CD4 Th1 phenotype.
Buatois V; Baillet M; Bécart S; Mooney N; Leserman L; Machy P
J Immunol; 2003 Dec; 171(11):5812-9. PubMed ID: 14634090
[TBL] [Abstract][Full Text] [Related]
2. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
Machy P; Serre K; Baillet M; Leserman L
J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
[TBL] [Abstract][Full Text] [Related]
3. CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity.
Lemos MP; Fan L; Lo D; Laufer TM
J Immunol; 2003 Nov; 171(10):5077-84. PubMed ID: 14607905
[TBL] [Abstract][Full Text] [Related]
4. Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells.
Ria F; Penna G; Adorini L
Eur J Immunol; 1998 Jun; 28(6):2003-16. PubMed ID: 9645382
[TBL] [Abstract][Full Text] [Related]
5. CD4+ Th-APC with acquired peptide/MHC class I and II complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responses.
Umeshappa CS; Huang H; Xie Y; Wei Y; Mulligan SJ; Deng Y; Xiang J
J Immunol; 2009 Jan; 182(1):193-206. PubMed ID: 19109150
[TBL] [Abstract][Full Text] [Related]
6. Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters.
Bosch B; Heipertz EL; Drake JR; Roche PA
J Biol Chem; 2013 May; 288(19):13236-42. PubMed ID: 23532855
[TBL] [Abstract][Full Text] [Related]
7. Regulated recruitment of MHC class II and costimulatory molecules to lipid rafts in dendritic cells.
Meyer zum Bueschenfelde CO; Unternaehrer J; Mellman I; Bottomly K
J Immunol; 2004 Nov; 173(10):6119-24. PubMed ID: 15528348
[TBL] [Abstract][Full Text] [Related]
8. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms.
Askew D; Chu RS; Krieg AM; Harding CV
J Immunol; 2000 Dec; 165(12):6889-95. PubMed ID: 11120813
[TBL] [Abstract][Full Text] [Related]
9. A model for antigen-specific T-cell anergy: displacement of CD4-p56(lck) signalosome from the lipid rafts by a soluble, dimeric peptide-MHC class II chimera.
Thomas S; Kumar R; Preda-Pais A; Casares S; Brumeanu TD
J Immunol; 2003 Jun; 170(12):5981-92. PubMed ID: 12794125
[TBL] [Abstract][Full Text] [Related]
10. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.
Kropshofer H; Spindeldreher S; Röhn TA; Platania N; Grygar C; Daniel N; Wölpl A; Langen H; Horejsi V; Vogt AB
Nat Immunol; 2002 Jan; 3(1):61-8. PubMed ID: 11743588
[TBL] [Abstract][Full Text] [Related]
11. CD154 plays a central role in regulating dendritic cell activation during infections that induce Th1 or Th2 responses.
Straw AD; MacDonald AS; Denkers EY; Pearce EJ
J Immunol; 2003 Jan; 170(2):727-34. PubMed ID: 12517934
[TBL] [Abstract][Full Text] [Related]
12. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
Feili-Hariri M; Falkner DH; Morel PA
J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
[TBL] [Abstract][Full Text] [Related]
13. CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation.
Clatza A; Bonifaz LC; Vignali DA; Moreno J
J Immunol; 2003 Dec; 171(12):6478-87. PubMed ID: 14662847
[TBL] [Abstract][Full Text] [Related]
14. Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells.
Tanaka Y; Koido S; Ohana M; Liu C; Gong J
J Immunol; 2005 Feb; 174(3):1274-80. PubMed ID: 15661883
[TBL] [Abstract][Full Text] [Related]
15. Trogocytosis of peptide-MHC class II complexes from dendritic cells confers antigen-presenting ability on basophils.
Miyake K; Shiozawa N; Nagao T; Yoshikawa S; Yamanishi Y; Karasuyama H
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1111-1116. PubMed ID: 28096423
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
[TBL] [Abstract][Full Text] [Related]
17.
Letendre C; Auger JP; Lemire P; Galbas T; Gottschalk M; Thibodeau J; Segura M
Front Immunol; 2018; 9():1199. PubMed ID: 29899744
[No Abstract] [Full Text] [Related]
18. Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells.
Serre K; Machy P; Grivel JC; Jolly G; Brun N; Barbet J; Leserman L
J Immunol; 1998 Dec; 161(11):6059-67. PubMed ID: 9834089
[TBL] [Abstract][Full Text] [Related]
19. Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes.
Otten LA; Tacchini-Cottier F; Lohoff M; Annunziato F; Cosmi L; Scarpellino L; Louis J; Steimle V; Reith W; Acha-Orbea H
J Immunol; 2003 Feb; 170(3):1150-7. PubMed ID: 12538670
[TBL] [Abstract][Full Text] [Related]
20. MHC class II-peptide complexes and APC lipid rafts accumulate at the immunological synapse.
Hiltbold EM; Poloso NJ; Roche PA
J Immunol; 2003 Feb; 170(3):1329-38. PubMed ID: 12538693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
